Cargando…

Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice

OBJECTIVES: This study was performed to analyze the risk factors for early mortality (EM) in elderly patients undergoing treatment for multiple myeloma (MM) in real-world clinical practice. METHODS: Retrospective data from 108 elderly patients who were newly diagnosed with MM from January 2007 to Ju...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Jun, Wang, Lingling, Zhou, Xin, Wang, Jing, Wang, Huan, Guo, Hongfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Clinical Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023076/ https://www.ncbi.nlm.nih.gov/pubmed/29584537 http://dx.doi.org/10.1177/0300060518757640

Ejemplares similares

Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience
por: Qian, Xifeng, et al.
Publicado: (2018)

Multiple myeloma: patient outcomes in real‐world practice
por: Yong, Kwee, et al.
Publicado: (2016)

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
por: Turner, Rose, et al.
Publicado: (2022)

Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice
por: Hulin, Cyrille, et al.
Publicado: (2018)

Health‐related quality of life of patients with multiple myeloma: A real‐world study in China
por: Li, Xiaozhe, et al.
Publicado: (2020)

Ixazomib‐based maintenance therapy after bortezomib‐based induction in patients with multiple myeloma not undergoing transplantation: A real‐world study
por: Shen, Man, et al.
Publicado: (2021)

Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
por: McQuilten, Zoe, et al.
Publicado: (2022)

INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma
por: Costello, Caitlin, et al.
Publicado: (2019)

Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma
por: Basali, Diana, et al.
Publicado: (2020)

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
por: Shragai, Tamir, et al.
Publicado: (2022)

The real-world outcomes of multiple myeloma patients treated with daratumumab
por: Szabo, Agoston Gyula, et al.
Publicado: (2021)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
por: Muñoz, Maria Nieves Lopez, et al.
Publicado: (2023)

Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients
por: Wang, Jing, et al.
Publicado: (2015)

Influence of changing trends in anaesthetic practice on morbidity and mortality in elderly patients undergoing lower limb surgery
por: Srilata, Moningi, et al.
Publicado: (2014)

Multiple Myeloma, Clinical Characteristics, and Increased COVID-19 Risk Using Real-World Data
por: Liu, Emily I., et al.
Publicado: (2021)

Impact of the Malnutrition on Mortality in Elderly Patients Undergoing Percutaneous Coronary Intervention
por: Chen, Liling, et al.
Publicado: (2021)

Front‐line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real‐world setting: A multicenter retrospective study in China
por: Bao, Li, et al.
Publicado: (2022)

Real World Multiple Myeloma Registry from Jordan, a Developing Country
por: Qasem, Farah, et al.
Publicado: (2022)

Real-world renal function among patients with multiple myeloma in the United States
por: Mikhael, Joseph, et al.
Publicado: (2021)

Patient‐reported pain severity and health‐related quality of life in patients with multiple myeloma in real world clinical practice
por: Ludwig, Heinz, et al.
Publicado: (2021)

Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen
por: Kim, Su-In, et al.
Publicado: (2022)

Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study
por: Wang, Yu-tong, et al.
Publicado: (2023)

Machine Learning–Based Overall Survival Prediction of Elderly Patients With Multiple Myeloma From Multicentre Real-Life Data
por: Bao, Li, et al.
Publicado: (2022)

Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study
por: Yang, Guang-Zhong, et al.
Publicado: (2021)

Clinical analysis of 40 multiple myeloma patients with extramedullary plasmacytoma of the head
por: Sun, Wan-jun, et al.
Publicado: (2016)

Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma
por: Hsu, Pei, et al.
Publicado: (2015)

Recognition of early mortality in multiple myeloma by a prediction matrix
por: Terebelo, Howard, et al.
Publicado: (2017)

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China
por: Tang, Wenjiao, et al.
Publicado: (2023)

Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs
por: Gooding, Sarah, et al.
Publicado: (2015)

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting
por: Richardson, Paul G., et al.
Publicado: (2018)

Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
por: Huang, Shang-Yi, et al.
Publicado: (2019)

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
por: Cottini, Francesca, et al.
Publicado: (2021)

Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study
por: Nasr, Fadi, et al.
Publicado: (2021)

Compliance With Vaccination Recommendations Among Patients With Multiple Myeloma: A Real World Experience
por: Ludwig, Heinz, et al.
Publicado: (2021)

Real‐world multiple myeloma front‐line treatment and outcomes by transplant in the United States
por: Richter, Joshua, et al.
Publicado: (2023)

P09: ATTRITION RATES IN MULTIPLE MYELOMA UNDER REAL WORLD CONDITIONS – AN ANALYSIS FROM THE AUSTRIAN MYELOMA REGISTRY
por: Benda, MA, et al.
Publicado: (2022)

Attrition Rates in Multiple Myeloma Treatment under Real World Conditions—An Analysis from the Austrian Myeloma Registry (AMR)
por: Benda, Magdalena A., et al.
Publicado: (2023)

Treatment of Multiple Myeloma in Elderly Patients: A Review of Literature and Practice Guidelines
por: Manapuram, Suresh, et al.
Publicado: (2018)

Comparative effectiveness of radiotherapy for early‐stage hormone receptor‐positive breast cancer in elderly women using real‐world data
por: Ali, Askal A., et al.
Publicado: (2018)

Ablation of paroxysmal and persistent atrial fibrillation in the very elderly real‐world data on safety and efficacy
por: Willy, Kevin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j7q2tmhkq3b5u4heua2shvnl97